187 related articles for article (PubMed ID: 33131917)
21. The changing role of H2-receptor antagonists in acid-related diseases.
Lamers CB
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
[TBL] [Abstract][Full Text] [Related]
22. [On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].
Lamers CB
Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1630-2. PubMed ID: 12966627
[TBL] [Abstract][Full Text] [Related]
23. [As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].
Poen AC; Otten MH
Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1632-6. PubMed ID: 12966628
[TBL] [Abstract][Full Text] [Related]
24. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
Geus WP
Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
[TBL] [Abstract][Full Text] [Related]
25. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
Tofil NM; Benner KW; Fuller MP; Winkler MK
J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
[TBL] [Abstract][Full Text] [Related]
26. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
Lazzaroni M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
[TBL] [Abstract][Full Text] [Related]
27. [Anti-ulcer drugs. Indications in adults. French Agency of the Safety of Health Products].
Presse Med; 2000 Jan; 29(2):86-94. PubMed ID: 10682037
[No Abstract] [Full Text] [Related]
28. [H2 blockers and antacids in gastrointestinal diseases].
Stein J; Rösch W
Pharm Unserer Zeit; 2007; 36(1):38-43. PubMed ID: 17283749
[No Abstract] [Full Text] [Related]
29. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
[TBL] [Abstract][Full Text] [Related]
30. The Role of Acid Suppressants in the Prevention of Anticoagulant-Related Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.
Bang CS; Joo MK; Kim BW; Kim JS; Park CH; Ahn JY; Lee JH; Lee BE; Yang HJ; Cho YK; Park JM; Kim BJ; Jung HK;
Gut Liver; 2020 Jan; 14(1):57-66. PubMed ID: 30974930
[No Abstract] [Full Text] [Related]
31. Medical treatments of GERD: the old and new.
Vela MF
Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
[TBL] [Abstract][Full Text] [Related]
32. Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies.
Heilmann RM; Berghoff N; Grützner N; Parnell NK; Suchodolski JS; Steiner JM
BMC Vet Res; 2017 Nov; 13(1):321. PubMed ID: 29115998
[TBL] [Abstract][Full Text] [Related]
33. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
Tanaka M; Banba M; Joko A; Moriyama Y
Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
[TBL] [Abstract][Full Text] [Related]
35. Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.
Biswas S; Benedict SH; Lynch SG; LeVine SM
BMC Med; 2012 Jun; 10():57. PubMed ID: 22676575
[TBL] [Abstract][Full Text] [Related]
36. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
[TBL] [Abstract][Full Text] [Related]
37. Acid suppression in critically ill patients: what does the evidence support?
Spirt MJ
Pharmacotherapy; 2003 Oct; 23(10 Pt 2):87S-93S. PubMed ID: 14587963
[TBL] [Abstract][Full Text] [Related]
38. Treatment of gastroesophageal reflux disease.
Pettit M
Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
[TBL] [Abstract][Full Text] [Related]
39. Overuse of acid suppressant drugs in patients with chronic renal failure.
Strid H; Simrén M; Björnsson ES
Nephrol Dial Transplant; 2003 Mar; 18(3):570-5. PubMed ID: 12584281
[TBL] [Abstract][Full Text] [Related]
40. Primary prevention of ulcers in patients taking aspirin or NSAIDs.
Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
